December 10, 2008 - Frost & Sullivan (F&S) awarded Zecotek Photonics Inc. (Zecotek) the 2009 Enabling Technology Award in the PET and PET/CT medical imaging markets in recognition of the its research and clinical validation for its next-generation scintillation crystals and solid-state photo detector technology.

"We are extremely impressed with Zecotek's best practices in strategic alliances and technology development of medical imaging products," said Travis Chong, industry analyst, Medical Devices, Healthcare of F&S. "We expect their advanced scintillation crystals and solid-state photo detectors to act as a springboard to delivering next-generation oncology and neurology imaging equipment, such as the first-ever combined PET/MRI scanner, accelerating the delivery of truly personalized medicine to the general public."

"Being recognized for our leading edge technologies, which allow for improved and less expensive oncology and neurology diagnostics, is second only to delivering better health care to more people," said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek. "At Zecotek we are driven by the needs of our community and our reward is seeing our new technologies being put into action and helping those around us."

Zecotek distinguished itself from its competitors through its best practices in strategic alliances and technology developments for its medical imaging products. Some of Zecotek’s achievements include:

1) Integrating a portfolio of technologies to create higher resolution and compact medical imaging devices;

2) Receiving patents for its LFS scintillation crystals in multiple countries including: USA, China, Europe, Russia, Japan and Canada;

3) Achieving a series of pending and granted patents for its novel MAPD solid-state photo detector;

4) Filing a number of patent applications for its important, novel Depth of Interaction design considerations.

"What truly stands out about Zecotek is that development, commercialization, and IP protection of its enabling technologies have all been accomplished since the company's inception only five years ago in 2003," concluded Mr. Chong.

For more information: www.frost.com and www.zecotek.com


Related Content

News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | PET Imaging

June 18, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 18, 2024
arrow
News | PET Imaging

June 14, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 14, 2024
arrow
News | FDA

June 10, 2024 — Siemens Healthineers announces the Food and Drug Administration clearance of the Biograph Trinion, a ...

Time June 10, 2024
arrow
News | Radiology Business

May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on ...

Time May 14, 2024
arrow
News | Cardiac Imaging

April 23, 2024 — CDL Nuclear Technologies, a pioneer in advanced diagnostic solutions, is proud to announce the launch ...

Time April 23, 2024
arrow
News | FDA

January 23, 2024 — Siemens Healthineers announces the Food and Drug Administration (FDA) clearance of syngo Virtual ...

Time January 23, 2024
arrow
News | Artificial Intelligence

January 23, 2024 — Quibim announced it has added an industry-leading cancer detection capability to its prostate tool ...

Time January 22, 2024
arrow
News | Radiology Business

December 27, 2023 — The American Roentgen Ray Society (ARRS) announced David M. Naeger, MD, as the 2024 ARRS ...

Time December 27, 2023
arrow
News | Radiopharmaceuticals and Tracers

December 6, 2023 — Philochem AG, a wholly owned subsidiary of Philogen S.p.A., and Blue Earth Diagnostics, a Bracco ...

Time December 06, 2023
arrow
Subscribe Now